Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063805

Chief Financial Officer gave up 356 shares (to pay taxes)

  • Chief Financial Officer acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ruffo Frank · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-12-18 Exercise or conversion : show line 1 in the form +1,250 162,765 D
2018-12-18 Shares withheld for taxes : show line 2 in the form −356 $6.30 $2,243 162,409 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-12-18 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,250 1,250 D
Loading xslF345X03/doc4.xml…